Sponsor

Shanghai Jiao Tong University School of Medicine

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Shanghai Jiao Tong University School of Medicine appears in 144 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials144
Recruiting shown19
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast CancerNCT07844941 · lead sponsor · 2026-07-22
RECRUITING
Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBCNCT07797218 · lead sponsor · 2026-07-01
RECRUITING
Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast CancerNCT07393425 · lead sponsor · 2026-02-02
RECRUITING
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes MellitusNCT07303803 · lead sponsor · 2026-01-01
RECRUITING
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast CancerNCT07371208 · lead sponsor · 2025-12-24
RECRUITING
Clinical Evaluation of Non-invasive Blood Glucose MeterNCT06796322 · lead sponsor · 2025-01-01
RECRUITING
Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BCNCT06500208 · lead sponsor · 2024-11-01
RECRUITING
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast CancerNCT06725940 · lead sponsor · 2024-11-01
RECRUITING
Magnetic Seizure Therapy for Psychotic DisordersNCT06581302 · lead sponsor · 2024-09-01
RECRUITING
ctDNA in HER2+ EBC Neoadjuvant TreatmentNCT07335081 · lead sponsor · 2024-02-01
RECRUITING
Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast CancerNCT05891561 · lead sponsor · 2023-11-01
RECRUITING
Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in ChinaNCT05735444 · lead sponsor · 2023-01-01
RECRUITING
Renal Artery Fibromuscular Dysplasia RegistryNCT05363748 · lead sponsor · 2021-10-01
RECRUITING
Overweight and Obesity and Puberty Development Cohort StudyNCT04113070 · lead sponsor · 2019-10-11
RECRUITING
The Diabetic Retinopathy Screening, Prevention and Control ProgramNCT04240652 · lead sponsor · 2018-06-05
RECRUITING
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer PatientsNCT03258320 · lead sponsor · 2015-01-01
RECRUITING
A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of BreastNCT02897700 · lead sponsor · 2013-01-01
RECRUITING
Genetics of Obesity in Chinese YoungsNCT01084967 · lead sponsor · 2009-03-01
RECRUITING
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung CancerNCT02889666 · lead sponsor · 2008-01-01
RECRUITING
A Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 DiabetesNCT07833228 · lead sponsor · 2026-10-08
NOT_YET_RECRUITING
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMNCT07570810 · lead sponsor · 2026-06-01
NOT_YET_RECRUITING
Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute PancreatitisNCT07816900 · lead sponsor · 2026-04-01
COMPLETED
Transcutaneous Electrical Acupoint Stimulation on Blood PressureNCT06537167 · lead sponsor · 2025-08-01
NOT_YET_RECRUITING
A Prospective Multicenter RCT Study of Deep Jugular Lymphovenous Anastomosis in the Treatment of Alzheimer's DiseaseNCT07060391 · lead sponsor · 2025-07-31
NOT_YET_RECRUITING
A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)NCT07102017 · lead sponsor · 2025-05-06
ACTIVE_NOT_RECRUITING
Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese MalesNCT06901726 · lead sponsor · 2025-03-31
NOT_YET_RECRUITING
Standardized Antihypertensive Treatment ProtocolNCT06790927 · lead sponsor · 2025-02-24
NOT_YET_RECRUITING
Identification of Pathogenic Bacteria of Diabetes Foot UlcerNCT06777810 · lead sponsor · 2025-01-31
NOT_YET_RECRUITING
Predictive Analysis of Diabetic Foot UlcerNCT06768554 · lead sponsor · 2024-10-31
ACTIVE_NOT_RECRUITING
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DMNCT06492330 · lead sponsor · 2024-07-19
COMPLETED
Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese MalesNCT06519604 · lead sponsor · 2024-07-17
ACTIVE_NOT_RECRUITING
Clinical Validation of mμSORS for Non-invasive Blood Glucose Detection in Non-diabetic SubjectsNCT06512077 · lead sponsor · 2024-07-11
COMPLETED
Monocular-Camera-Based Mobile Exergame for Type 2 Diabetes PreventionNCT06950528 · lead sponsor · 2024-01-01
COMPLETED
National Multicenter Registry for Pediatric End-Stage Heart Failure in ChinaNCT06927440 · lead sponsor · 2023-12-01
ENROLLING_BY_INVITATION
RJBC-APP and Breast Cancer Treatment ComplianceNCT05921331 · lead sponsor · 2023-10-10
COMPLETED
Preclinical Research of mμSORS for Noninvasive Blood Glucose DetectionNCT05921344 · lead sponsor · 2023-07-11
COMPLETED
Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast CancerNCT05843292 · lead sponsor · 2023-07-01
NOT_YET_RECRUITING
Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer PatientsNCT05901025 · lead sponsor · 2023-06-05
NOT_YET_RECRUITING
MRD in High-risk EBCNCT06566729 · lead sponsor · 2023-06-01
ACTIVE_NOT_RECRUITING
Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in PatientsNCT05990517 · lead sponsor · 2023-02-22
UNKNOWN
Allogeneic Transplantation of Expanded Pancreatic Islet CellsNCT05990530 · lead sponsor · 2023-02-22
UNKNOWN
Chinese Endocrinologists Health Education StudyNCT05715307 · lead sponsor · 2023-02-13
COMPLETED
Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial FibrillationNCT05528419 · lead sponsor · 2023-02-06
COMPLETED
Limonene for Pulmonary Nodule ChemopreventionNCT05525260 · lead sponsor · 2023-02-01
UNKNOWN
Group Education Helps Smoking Cessation and Hypertension ControlNCT05530083 · lead sponsor · 2022-10-12
NOT_YET_RECRUITING
Clinical Validation of mμSORS for Noninvasive Blood Glucose DetectionNCT05504005 · lead sponsor · 2022-10-08
COMPLETED
Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 DiabetesNCT05270343 · lead sponsor · 2022-06-01
UNKNOWN
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset DiabetesNCT05294653 · lead sponsor · 2022-06-01
NOT_YET_RECRUITING
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.NCT05330637 · lead sponsor · 2022-03-03
UNKNOWN
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic HypertensionNCT05165251 · lead sponsor · 2022-01-04
UNKNOWN
The Role of Circadian Rhythm in the Effect of Sleep Intervention on Obesity Prevention in Early ChildhoodNCT05159141 · lead sponsor · 2022-01-01
UNKNOWN
Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.NCT04929600 · lead sponsor · 2021-11-28
UNKNOWN
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.NCT04931108 · lead sponsor · 2021-09-27
UNKNOWN
Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 DiabetesNCT04797442 · lead sponsor · 2021-07-15
UNKNOWN
Impact of Exercise Intervention on the PhenomeNCT04919603 · lead sponsor · 2021-06-15
UNKNOWN
The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart FailureNCT04455178 · lead sponsor · 2020-09-23
UNKNOWN
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity BiotypesNCT04853485 · lead sponsor · 2020-08-01
UNKNOWN
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial FibrillationNCT04111419 · lead sponsor · 2020-07-01
ACTIVE_NOT_RECRUITING
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerNCT04398914 · lead sponsor · 2020-05-30
ACTIVE_NOT_RECRUITING
Phase II Clinical Trial of Percutaneous Ventricular Restoration Using Heartech® Device Preventing Heart Failure Post Myocardial Infarction (The Partical Study)NCT04039256 · lead sponsor · 2020-01-02
UNKNOWN

Drugs studied in this sponsor's trials

47 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Shanghai Jiao Tong University School of Medicine as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
pertuzumab5
docetaxel4
losartan4
berberine3
metformin3
placebo3
saxagliptin3
trastuzumab3
pertuzumab RxCUI 1298944 · Lead sponsor in 5 linked trial(s) · 4 currently recruiting 5 trials docetaxel RxCUI 72962 · Lead sponsor in 4 linked trial(s) · 3 currently recruiting 4 trials losartan RxCUI 52175 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials berberine RxCUI 1437 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 3 trials metformin RxCUI 6809 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 2 currently recruiting 3 trials saxagliptin RxCUI 857974 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials trastuzumab RxCUI 224905 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 3 trials amlodipine 5 MG / atorvastatin 10 MG Oral Tablet RxCUI 597977 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials bicalutamide RxCUI 83008 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials carboplatin RxCUI 40048 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials glipizide RxCUI 4821 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials paclitaxel protein-bound RxCUI 486610 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials sacubitril / valsartan RxCUI 1656339 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials sitagliptin RxCUI 593411 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials acarbose RxCUI 16681 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ado-trastuzumab emtansine RxCUI 1371041 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial amisulpride RxCUI 46303 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial amlodipine RxCUI 17767 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial amlodipine 5 MG / atorvastatin 20 MG Oral Tablet RxCUI 597980 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial aripiprazole RxCUI 89013 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial atenolol RxCUI 1202 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial carvedilol RxCUI 20352 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial cisplatin RxCUI 2555 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor118
collaborator26
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.